Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-076902
Filing Date
2026-02-26
Accepted
2026-02-26 16:31:07
Documents
106
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adpt-20251231.htm   iXBRL 10-K 4099267
2 EX-19 adpt-ex19.htm EX-19 173268
3 EX-23.1 adpt-ex23_1.htm EX-23.1 6751
4 EX-31.1 adpt-ex31_1.htm EX-31.1 19004
5 EX-31.2 adpt-ex31_2.htm EX-31.2 20574
6 EX-32.1 adpt-ex32_1.htm EX-32.1 11950
7 EX-32.2 adpt-ex32_2.htm EX-32.2 13342
8 GRAPHIC img83932212_0.gif GRAPHIC 43004
9 GRAPHIC img131463513_0.jpg GRAPHIC 99831
10 GRAPHIC img131463513_1.jpg GRAPHIC 631041
11 GRAPHIC img131463513_2.gif GRAPHIC 97392
  Complete submission text file 0001193125-26-076902.txt   18021857

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20251231.xsd EX-101.SCH 1784059
109 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20251231_htm.xml XML 3308907
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38957 | Film No.: 26689401
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)